Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PREVENT-2024

Financiado

Cerrado

MOVING FROM BIOMARKERS TO MECHANISM ORIENTED PREVENTION OF CARDIOMETABOLIC DISEA...

MOVING FROM BIOMARKERS TO MECHANISM ORIENTED PREVENTION OF CARDIOMETABOLIC DISEASE Increasing occurrence of obesity and diabetes is the major threat to cardiovascular health of our century. Whereas the field is saturated with omics strategies aimed at improving prediction of cardiometabolic disease (CMD), mechan... ver más

31/12/2025

LUNDS UNIVERSITET

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

LUNDS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-11-18

ERC-2019-ADG: ERC Advanced Grant

I+D

Cerrada hace 5 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

LUNDS UNIVERSITET

2.50M€ | Lider

Rumitag

923.86K€ | Participante

Proyectos interesantes

LifeWithoutInsulin

Medical Technol...

Data Science

2M€ Cerrado

AGL2011-23810

Medical Technol...

Data Science

169K€ Cerrado

PID2021-126888OA-I00

Medical Technol...

Data Science

194K€ Cerrado

SAF2011-28011

Medical Technol...

Health Informat...

85K€ Cerrado

SAF2014-56995-JIN

Medical Technol...

Data Science

204K€ Cerrado

Solving CKD

Medical Technol...

Data Science

268K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 61 meses Fecha Inicio: 2020-11-18
Fecha Fin: 2025-12-31

Líder del proyecto

LUNDS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Increasing occurrence of obesity and diabetes is the major threat to cardiovascular health of our century. Whereas the field is saturated with omics strategies aimed at improving prediction of cardiometabolic disease (CMD), mechanism-orientated prevention strategies, which is what the population calls for, are lacking. We here propose three completely new and high-risk strategies to prevent CMD in large subsets of the population, who have elevated risk due to measurable endocrine abnormalities. SUBPROJECT 1: We test if the increased CMD risk linked to high levels of the intestinal fat absorption and storage promoting hormone neurotensin (NTS), can be improved by: (A) blockade of NTS using monoclonal antibodies in mice and (B) inhibition of NTS secretion and intestinal fat uptake with the drug orlistat in humans. SUBPROJECT 2: High plasma levels of vasopressin (VP) (present in 25% of the population) is a strong risk factor for later CMD and the dominating cause of high VP is low water intake. We therefore test if the elevated CMD risk in subjects with high VP can be reduced by increasing water intake in a large 12-month randomized trial of 1.5 L water supplementation vs control therapy. SUBPROJECT 3: Aderenomedullin (ADM), whose endothelial secretion is enhanced in obesity, has beneficial effects on the intravascular wall but in the extravascular space, to which it diffuses freely, it may promote diabetes. We investigate how long-term increase and decrease of levels of bioactive ADM in the intra- and extravascular compartments, respectively, affect atherosclerosis and glucose metabolism in mice. In humans we test if a monoclonal antibody, which traps ADM in the circulation (while still allowing it to bind to its endothelial receptors) and drains it from the extravascular space, improves vascular function and glucose metabolism. We provide completely novel, mechanism-orientated and near-future applicable strategies for primary prevention of CMD.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores